Technical analysis from Karyopharm Therapeutics (KPTI, NASDAQ:KPTI) on the NASDAQ Stock Exchange (NASDAQ). Download the latest price data & trading signals

Karyopharm Therapeutics
+ Share

Moving Average Envelope /
Overbought signal continues for Karyopharm Therapeutics indicating downward price movement is likely

[BEARISH]: Karyopharm Therapeutics current trading has maintained the Envelope Bands to overbought status and signalled the continuation of the bearish trading conditions. Currently, the Upper Band is 12.9150.

Elders Force Index /
Karyopharm Therapeutics: Direction, extent & volume have increased in recent trading [Buying Pressure]

[BULLISH]: Karyopharm Therapeutics current price has highlighted recent buying pressure. Currently, the Elders Force Index is 146642.

Average True Range /
Karyopharm Therapeutics: Average True Range (0.87) has confirmed an downtrend is present

[Bearish]: Average True Range has confirmed an downtrend is present. Karyopharm Therapeutics has a TR of 0.85, and an ATR(14) of 0.87.

Triangular Moving Average /
Price continues to trade above the Triangular Moving Average(5) for KPTI

[BULLISH]: Karyopharm Therapeutics currently has a confirmed uptrend. Recent trading has caused the TMA 5 day average to exceed the closing price confirming the short term trend following indicator. Currently, the return on TMA5 is 1.4%.

Fibonacci Extensions /
Limit order for a short position has been identified for Karyopharm Therapeutics @$9.67

Karyopharm Therapeutics has moved above the 161.8% level ($9.67) [Bearish]. Look for a short limit order entry near this point. Exit price for KPTI should be set @$12.84 & short position stoploss for Karyopharm Therapeutics should be set at $6.5

Top companies for
NASDAQ Stock Exchange
Advertisment
Short Trend /
First timeframe trend of Karyopharm Therapeutics remains as an Uptrend

[BULLISH]: Karyopharm Therapeutics is in an uptrend in the short term timeframe. The current rally number is 2 & the highest rally count for the LTM is 3

Medium Trend /
Karyopharm Therapeutics: 2nd timeframe trend Uptrend remains intact

KPTI: Medium Term Current Signal -> (1) 16 Feb: BULLISH (2) 15 Feb: BULLISH (3) 14 Feb: BULLISH

Rate of Change /
ROC continues to rise for Karyopharm Therapeutics signalling an uptrend will persist

[BULLISH]: Karyopharm Therapeutics currently has positive rate of change of 20.5%. This means the current price is greater than the price 14 days ago and therefore gaining momentum & is a leading indicator of price movement in the upward direction

Elder Ray Index /
[Bullish]: Recent trading has driven price above the consensus of value for KPTI

[BULLISH]: Karyopharm TherapeuticsElder Ray Index is signalling a Bullish movementERI is 2.137 indicating bull power. Prices are being driven above the consensus of value for KPTI during the last trading session [Buying Pressure]

Close Tod Vs Range Tod /
Karyopharm Therapeutics: Sellers are in control at the market close.

[BEARISH]: Karyopharm Therapeutics sellers in control. This is the first day of seller commitment for Karyopharm Therapeutics adding strength to an downtrend in the first timeframe & highlights the lack of commitment of buyers to carry positions overnight Over the last 12 months there has been 22 trading days with the closing price in the lower part of the range giving a confirmation ratio of 32.8%. Over the last month there has been 2 trading days with the closing price in the lower range giving a confirmation ratio of 18.2%. Currently this quarter, closing price has spent 3 days in the lower price range compared to 4 days in the upper range giving a ratio of 0.8x.

Aroon Oscillator /
Daily trading has confirmed an Aroon strong uptrend (84) for Karyopharm Therapeutics

[BULLISH]: Karyopharm Therapeutics has a current ARU(25) of 100 and a current ARD(25) of 16

Demarks Pivot Points /
Karyopharm Therapeutics has broken the first DeMark resistance point ($15.24) [Bullish]

Karyopharm Therapeutics has broken the first DeMark resistance point ($15.24) [Bullish]. Look for a long limit order entry near this point. Exit price for KPTI should be set @$15.72 & Stoploss for Karyopharm Therapeutics should be set at $14.87

Exponential Moving Average /
[Uptrend]: Recent trading for KPTI indicates ST trend is likely to continue

[BULLISH]: Karyopharm Therapeutics currently has a confirmed uptrend. Recent trading has caused the EMA 5 day average to exceed the closing price confirming the short term trend following indicator. Currently, the return on EMA5 is 1.4%.

Ease of Movement /
Karyopharm Therapeutics was easily moved upward on low volume in recent trading [Bullish]

KPTI: EOM Current Signal -> (1) 16 Feb: BULLISH EASY (2) 15 Feb: BULLISH EASY (3) 14 Feb: BULLISH EASY

Closing Price /
[Bullish]: Karyopharm Therapeutics has beaten previous close by 1.4 %

[BULLISH]: Karyopharm Therapeutics current uptrend in the first timeframe. Currently, the Close is $14.98.

Simple Moving Average /
The SMA trend following signal is still current for Karyopharm Therapeutics [Bullish]

KPTI: SMA(5) Current Signal -> (1) 16 Feb: BEARISH (2) 15 Feb: BEARISH (3) 14 Feb: BEARISH

Volume Rate of Change /
Karyopharm Therapeutics:Volume rate of Change (42)

KPTI: VROC Current Signal -> (1) 16 Feb: BULLISH (2) 15 Feb: BULLISH (3) 14 Feb: BULLISH

High Price /
Recent trading for Karyopharm Therapeutics has surpassed the previous high by 3.7 %

[BULLISH]: Karyopharm Therapeutics current uptrend in the first timeframe. Currently, the HIGH is 3.7 %.

Pivot Points /
Karyopharm Therapeutics has moved above the R1 pivot point ($15.474) [Bullish]

Karyopharm Therapeutics has broken the first resistance point ($15.474) [Bullish]. Look for a long limit order entry near this point. Exit price for KPTI should be set @$15.967 & Stoploss for Karyopharm Therapeutics should be set between $14.267 & $13.774

Chaikin Money Flow /
CMF has positive divergence between price and volume

[BULLISH]: Karyopharm Therapeutics current price has highlighted recent buying pressure and the continuation of a bullish trading conditions. Currently, the CMF is 0.28. The bullish signal has been active for 0 day. During the quarter, the highest CMF value was 0.32

Accumulation / Distribution /
KPTI: Current trading activity signals accumulation is active

[BULLISH]: Karyopharm Therapeutics current accumulation has given strength to the share price and the continuation of bullish trading conditions.

Weighted Moving Average /
[Bullish]: Trend following indicator for KPTI highlights upward price direction is likely

[BULLISH]: Karyopharm Therapeutics currently has a confirmed uptrend. Recent trading has caused the WMA 5 day average to exceed the closing price confirming the short term trend following indicator. Currently, the return on WMA5 is 1.4%.

On Balance Volume /
Traders are currently accumulating Karyopharm Therapeutics

[BULLISH]: Karyopharm Therapeutics current price has highlighted recent accumulation. Currently, the OBV is 4.78225e+006.

Commodity Channel Index /
Karyopharm Therapeutics: Potential CCI trend reversal has been identified

[BEARISH]: Karyopharm Therapeutics current trading has maintained the Commodity Channel Index to overbought status and signalled the continuation of the bearish trading conditions. Currently, the CCI is 160. KPTI received a confirmed CCI crossover on the Feb 7 2018.The bearish signal has been active for 0 day. During the quarter, the highest CCI value was 299.

Money Flow Index /
MFI Overbought signal is still current for Karyopharm Therapeutics

[BULLISH]: Karyopharm Therapeutics current trading has maintained the money flow index oversold status and signalled the continuation of the bullish trading conditions. Currently, the MFI is 82.96. The bullish signal has been active for 0 days. During the quarter, the lowest MFI value was 46.44.

Sine Weighted Moving Average /
Karyopharm Therapeutics: Closing price $14.98 is above the SWMA(5) @$14.371

[BULLISH]: Karyopharm Therapeutics currently has a confirmed uptrend. Recent trading has caused the SWMA 5 day average to exceed the closing price confirming the short term trend following indicator. Currently, the return on SWMA5 is 1.4%.

See More   See more results
Advertisment
Advertisment
back to top